Showing results (171-180 of 295) with videos related to

Sort By:
Pageof 30
Urology|February 1, 2020
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the TestisGregory J Nason, Laura Donahoe, Marc de Perrot, et al.
JAMA Network Open|July 26, 2021
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal CancerKenneth L Kehl, Gregory J Riely, Eva M Lepisto, et al.
ESMO Open|June 5, 2025
Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancerM J Elliott, J Kim, A Dou, et al.
Addiction Neuroscience|August 1, 2024
Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonismMadigan L Bedard, Xi-Ping Huang, Jackson G Murray, et al.
Genomics|April 23, 2013
Clinical genomics information management software linking cancer genome sequence and clinical decisionsStuart Watt, Wei Jiao, Andrew M K Brown, et al.
NPJ Precision Oncology|May 5, 2026
Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profilingCarlos Diego Holanda Lopes, Hsin-Ta Wu, Katharine Dilger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer PatientsBritt I Drögemöller, Beth Brooks, Carol Critchley, et al.
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Journal for Immunotherapy of Cancer|August 14, 2021
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomasSarina A Piha-Paul, Ravit Geva, Tira J Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)J Mateo, D Chakravarty, R Dienstmann, et al.
Pageof 30